Bruker Corporation (NASDAQ: BRKRP) Stock Competitors & Peer Comparison
See BRKRP's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BRKRP and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BRKRP | $428.16 | -2.25% | 8.6B | 234.03 | $1.84 | +0.34% |
| ALC | $74.47 | +1.21% | 35.8B | 23.11 | $3.18 | +0.49% |
| STE | $233.85 | -1.16% | 23B | 22.65 | $10.42 | +1.07% |
| DRTSW | $3.81 | +6.58% | 1.5B | -6.02 | -$0.65 | N/A |
| MASS | $10.20 | +1.80% | 414.8M | -16.85 | -$0.60 | N/A |
| SI | $19.58 | +1.24% | 398.8M | -10.04 | -$1.91 | N/A |
| MOBI | $11.59 | +0.61% | 388.3M | -0.62 | -$18.78 | N/A |
| EDAP | $4.76 | -0.52% | 178.2M | -5.80 | -$0.82 | N/A |
| NYXH | $1.60 | +0.95% | 158.1M | -0.63 | -$2.52 | N/A |
| APYX | $3.06 | +2.34% | 128M | -13.82 | -$0.22 | N/A |
Stock Comparison
Alcon Inc. (NYSE: ALC)
BRKRP vs ALC Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, ALC has a market cap of 35.8B. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while ALC trades at $74.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas ALC's P/E ratio is 23.11. In terms of profitability, BRKRP's ROE is -0.03%, compared to ALC's ROE of +0.03%. Regarding short-term risk, BRKRP is similarly volatile compared to ALC. This indicates similar risk in terms of short-term price fluctuations for BRKRP.Check ALC's competition here
STERIS plc (NYSE: STE)
BRKRP vs STE Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, STE has a market cap of 23B. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while STE trades at $233.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas STE's P/E ratio is 22.65. In terms of profitability, BRKRP's ROE is -0.03%, compared to STE's ROE of +0.11%. Regarding short-term risk, BRKRP is more volatile compared to STE. This indicates higher risk in terms of short-term price fluctuations for BRKRP.Check STE's competition here
Alpha Tau Medical Ltd. (NASDAQ: DRTSW)
BRKRP vs DRTSW Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, DRTSW has a market cap of 1.5B. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while DRTSW trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas DRTSW's P/E ratio is -6.02. In terms of profitability, BRKRP's ROE is -0.03%, compared to DRTSW's ROE of -1.38%. Regarding short-term risk, BRKRP is less volatile compared to DRTSW. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check DRTSW's competition here
908 Devices Inc. (NASDAQ: MASS)
BRKRP vs MASS Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, MASS has a market cap of 414.8M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while MASS trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas MASS's P/E ratio is -16.85. In terms of profitability, BRKRP's ROE is -0.03%, compared to MASS's ROE of -0.25%. Regarding short-term risk, BRKRP is less volatile compared to MASS. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check MASS's competition here
Shoulder Innovations, Inc. (NYSE: SI)
BRKRP vs SI Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, SI has a market cap of 398.8M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while SI trades at $19.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas SI's P/E ratio is -10.04. In terms of profitability, BRKRP's ROE is -0.03%, compared to SI's ROE of -0.24%. Regarding short-term risk, BRKRP is less volatile compared to SI. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check SI's competition here
Mobia Medical, Inc. Common Stock (NASDAQ: MOBI)
BRKRP vs MOBI Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, MOBI has a market cap of 388.3M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while MOBI trades at $11.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas MOBI's P/E ratio is -0.62. In terms of profitability, BRKRP's ROE is -0.03%, compared to MOBI's ROE of -15.96%. Regarding short-term risk, BRKRP is less volatile compared to MOBI. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check MOBI's competition here
Edap Tms S.a. (NASDAQ: EDAP)
BRKRP vs EDAP Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, EDAP has a market cap of 178.2M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while EDAP trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas EDAP's P/E ratio is -5.80. In terms of profitability, BRKRP's ROE is -0.03%, compared to EDAP's ROE of -1.49%. Regarding short-term risk, BRKRP is less volatile compared to EDAP. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check EDAP's competition here
Nyxoah S.A. (NASDAQ: NYXH)
BRKRP vs NYXH Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, NYXH has a market cap of 158.1M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while NYXH trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas NYXH's P/E ratio is -0.63. In terms of profitability, BRKRP's ROE is -0.03%, compared to NYXH's ROE of -1.80%. Regarding short-term risk, BRKRP is less volatile compared to NYXH. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check NYXH's competition here
Apyx Medical Corporation (NASDAQ: APYX)
BRKRP vs APYX Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, APYX has a market cap of 128M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while APYX trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas APYX's P/E ratio is -13.82. In terms of profitability, BRKRP's ROE is -0.03%, compared to APYX's ROE of -0.79%. Regarding short-term risk, BRKRP is less volatile compared to APYX. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check APYX's competition here
Spectral AI, Inc. (NASDAQ: MDAI)
BRKRP vs MDAI Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, MDAI has a market cap of 55.1M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while MDAI trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas MDAI's P/E ratio is -3.84. In terms of profitability, BRKRP's ROE is -0.03%, compared to MDAI's ROE of +1.21%. Regarding short-term risk, BRKRP is less volatile compared to MDAI. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check MDAI's competition here
WORK Medical Technology Group Ltd. Class A (NASDAQ: WOK)
BRKRP vs WOK Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, WOK has a market cap of 5.1M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while WOK trades at $2.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas WOK's P/E ratio is N/A. In terms of profitability, BRKRP's ROE is -0.03%, compared to WOK's ROE of -0.07%. Regarding short-term risk, BRKRP is less volatile compared to WOK. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check WOK's competition here
ENvue Medical, Inc. (NASDAQ: FEED)
BRKRP vs FEED Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, FEED has a market cap of 3.7M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while FEED trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas FEED's P/E ratio is -0.01. In terms of profitability, BRKRP's ROE is -0.03%, compared to FEED's ROE of -0.44%. Regarding short-term risk, BRKRP is less volatile compared to FEED. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check FEED's competition here
QTREX Quantum Ltd. Warrant (NASDAQ: QTEXW)
BRKRP vs QTEXW Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, QTEXW has a market cap of 3.5M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while QTEXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas QTEXW's P/E ratio is -0.01. In terms of profitability, BRKRP's ROE is -0.03%, compared to QTEXW's ROE of N/A. Regarding short-term risk, BRKRP is less volatile compared to QTEXW. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check QTEXW's competition here
iTonic Holdings Ltd. (NASDAQ: ITOC)
BRKRP vs ITOC Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, ITOC has a market cap of 2.7M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while ITOC trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas ITOC's P/E ratio is -0.94. In terms of profitability, BRKRP's ROE is -0.03%, compared to ITOC's ROE of -0.94%. Regarding short-term risk, BRKRP is less volatile compared to ITOC. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check ITOC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
BRKRP vs BIAFW Comparison August 2026
Bruker Corporation (NASDAQ: BRKRP) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BRKRP stands at 8.6B. In comparison, BIAFW has a market cap of 2.5M. Regarding current trading prices, BRKRP is priced at $428.16 on the NASDAQ, while BIAFW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BRKRP currently has a P/E ratio of 234.03, whereas BIAFW's P/E ratio is 0.27. In terms of profitability, BRKRP's ROE is -0.03%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, BRKRP is less volatile compared to BIAFW. This indicates lower risk in terms of short-term price fluctuations for BRKRP.Check BIAFW's competition here